Literature DB >> 10627940

Trisomies 13 and 18: prenatal diagnosis and epidemiologic studies in Hawaii, 1986-1997.

M B Forrester1, R D Merz.   

Abstract

Using a birth defects registry, this study examined the influence of prenatal diagnosis and elective termination of pregnancy on trisomy 13 and trisomy 18 prevalence in Hawaii between 1986 and 1997. The investigation also evaluated the impact of various demographic factors on risk for the aneuploidies. Forty-seven cases of trisomy 13 and 116 cases of trisomy 18 were identified. The total prevalence of trisomy 13 was 1.91 per 10,000 births and of trisomy 18 was 4.71 per 10,000 births. Elective terminations accounted for 38.3% of trisomy 13 cases and 48.3% of trisomy 13 cases. The 1-year mortality rate for trisomy 13 was 89.5% and for trisomy 18 was 74.3%. Rates for both aneuploidies increased during the time period. The racial/ethnic group with the highest prevalence of both anomalies was Far East Asian. The aneuploidies were more common in metropolitan Honolulu than the rest of Hawaii. Demographic factors demonstrated differences in risk for trisomies 13 and 18, although most of these differences appeared to be due, at least in part, to differences in maternal age distribution. For the secular trend, increased prenatal diagnosis of the anomalies also contributed to the observed increase.

Entities:  

Mesh:

Year:  1999        PMID: 10627940     DOI: 10.1089/gte.1999.3.335

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  7 in total

1.  A study of a rare chromosomal disorder: mosaic 46, XX, del (18)(p11.2)/46, XX, i(18q).

Authors:  Dan Peng; Pan-Pan Long; Bo Wen; Rong-Hui Yu
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

2.  Microtia in All the Siblings of a Family: A Rare Case.

Authors:  Somashekar Gejje; Brijesh Mishra; Amrita Anandkumar Hongal
Journal:  J Clin Diagn Res       Date:  2017-06-01

3.  Expanding diagnostic testing beyond cytogenetics: implications for birth defects research and surveillance.

Authors:  Jodi M Jackson; Charlotte M Druschel; Stuart K Shapira
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-11-06

4.  Better prognosis in newborns with trisomy 13 who received intensive treatments: a retrospective study of 16 patients.

Authors:  Keiko Tsukada; George Imataka; Hiroshi Suzumura; Osamu Arisaka
Journal:  Cell Biochem Biophys       Date:  2012-07       Impact factor: 2.194

5.  A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States.

Authors:  Brandon S Walker; Richard E Nelson; Brian R Jackson; David G Grenache; Edward R Ashwood; Robert L Schmidt
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

Review 6.  The trisomy 18 syndrome.

Authors:  Anna Cereda; John C Carey
Journal:  Orphanet J Rare Dis       Date:  2012-10-23       Impact factor: 4.123

7.  Clinical features and survival in individuals with trisomy 18: A retrospective one-center study of 44 patients who received intensive care treatments.

Authors:  George Imataka; Hiroshi Suzumura; Osamu Arisaka
Journal:  Mol Med Rep       Date:  2016-01-22       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.